Automation and labor-saving measures in China and their transfer to Vietnam
First written in FY2016. 2 of 6 entries say "Advanced", first in FY2017. Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024DroppedAnnual reportThe filing contains no specific description of measures concerning automation and labor saving in China production or the transfer of production to Vietnam.
- FY2018RestatedAnnual report
「Profit improved significantly, partly because the cost ratio, which had deteriorated in the previous fiscal year due to soaring material costs and other factors, improved through productivity gains including increased outsourcing at the Chinese subsidiary.」
The company continued to report the effects of productivity gains and cost-ratio improvements resulting from increased outsourcing and other measures at the Chinese subsidiary. - FY2018-Q3RestatedAnnual report
「Profit improved significantly, partly because the cost ratio, which had deteriorated in the same period of the previous year due to soaring material costs and other factors, improved through productivity gains including increased outsourcing at the Chinese subsidiary.」
The company continued to report the effects of productivity gains and cost-ratio improvements resulting from increased outsourcing and other measures at the Chinese subsidiary. - FY2018-Q2AdvancedAnnual report
「Profit also improved significantly, partly because the cost ratio, which had deteriorated in the same period of the previous year due to soaring material costs and other factors, recovered earlier than expected through productivity improvements including increased outsourcing at the Chinese subsidiary.」
The company described the effects of production optimization, including increased outsourcing at the Chinese subsidiary and an earlier-than-expected recovery in the cost ratio through productivity improvements. - FY2017AdvancedAnnual report
「In the medical and health equipment business, the company established production systems at factories operated by its consolidated subsidiaries in Vietnam and China, advanced new product development centered on its development and technology center, and acquired manufacturing equipment at other consolidated subsidiaries. Capital expenditure totaled ¥367 million.」
The company established production systems at factories in China and Vietnam and made ¥367 million in capital expenditure in the medical and health equipment business. - FY2016First statedAnnual report
「To address this, the company is first improving productivity by enhancing production processes and promoting automation and labor-saving measures. Alongside expanding outsourcing, it is progressively transferring production to A&D Vietnam Limited, a Vietnamese production subsidiary established in the previous consolidated fiscal year, to optimize production.」
To address rising labor costs in China, the company began optimizing production by combining process improvements, automation and labor-saving measures, outsourcing, and the transfer of production to Vietnam.